Special Issue "Bioassay-Guided Isolation of Marine Natural Products for Drug Discovery"
A special issue of Marine Drugs (ISSN 1660-3397).
Deadline for manuscript submissions: 20 June 2019
Dr. Rob Keyzers
1. School of Chemical & Physical Sciences, and Center For Biodiscovery, Victoria University of Wellington, Wellington 6012, New Zealand2. Maurice Wilkins Centre for Molecular Biodiscovery, Auckland, New Zealand
Website 1 | Website 2 | E-Mail
Phone: +64 4 4635117
Interests: Identification of novel; biologically active marine natural products; metabolomics of marine organisms; chemical ecology; spectroscopic identification of complex molecules
From the potential human harm caused by the exquisitely potent dinoflagellate cytotoxins, maitotoxin and brevetoxin, through the knowledge gained regarding cellular function and metabolism from the use of latrunculin and laulimalide, right through to new blockbuster anticancer drugs like Eribulin mesylate and Trabectedin, the bioassay-guided isolation of new marine natural products has informed science and helped save many lives over the past half century. The new and exciting molecules sourced from the marine environment are varied in structure and, most importantly, the wide ranging and diverse potent bioactivities they possess. With a significantly greater number of phyla represented in our marine environments than that found on land, the sheer biodiversity found in the oceans, coupled with difficulties, and hence opportunities for obtaining marine organisms, continue to make investigations of marine natural products a lucrative area for medicinal and biochemical research.
Given the great value still waiting to be discovered from the life within our planet’s oceans, as the Guest Editor of this Special Issue of Marine Drugs, I personally invite you to contribute your latest research describing bioassay-guided isolation and identification of novel, bioactive marine natural products, from any marine-based organisms.
Dr. Rob Keyzers
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Biological activity
- Phenotypic assay
- Enzyme inhibition assay
- Mode of action
- Structural elucidation
- Bioassay guided fractionation